All Articles
Now that CMS has finally started paying for patient navigation, how do you ensure
you’re using the new billing codes correctly? Here’s what to know now to equip
yourself and your team. Read More ›
By bridging the gap between art and medicine, the future of patient-centered care may include innovative complementary therapy to enhance the healing journey. Read More ›
Office Managers: Have you considered strategies that give you the opportunity to invest
in yourself? (Not to mention, spark your leadership creativity, innovation, and
problem-solving skills?) Read More ›
The CMS decision to update the 2024 Physician Fee Schedule will expand access to care. Read More ›
Alternate Funding Programs claim to offer self-insured employers solutions to save money on specialty drugs, but at what cost? Read More ›
By Phoebe Starr
News you can use from the San Antonio Breast Cancer Symposium. Read More ›
There’s a sound researchers want your patients to hear—the sound of a cancer cell being destroyed. Read More ›
Do the data support the incorporation of circulating tumor DNA testing as part of
routine surveillance? Read More ›
The results from this study have the potential to be practice-changing for patients with
MSI-H/dMMR metastatic colorectal cancer. Read More ›
On November 22, 2023, the FDA approved efbemalenograstim alfa-vuxw (Ryzneuta; Evive Biotech) subcutaneous injection, a novel long-acting granulocyte colony-stimulating factor (G-CSF), for the prevention and treatment of febrile neutropenia in adults with nonmyeloid malignancies who are receiving myelosuppressive chemotherapy associated with a clinically significant incidence of febrile neutropenia. Read More ›